ReAlta Life Sciences Announces Poster Presentation at the European Respiratory Society 2023 International Congress
ReAlta Life Sciences (“ReAlta”), Inc., a clinical-stage biotech company addressing life-threatening rare diseases through harnessing the power of the immune system, today announced that it will be presenting additional clinical data from its Phase 1b trial in healthy volunteers on RLS-0071 at the European Respiratory Society 2023 International Congress taking place in Milan, Italy on 9-13 September, 2023. RLS-0071, the Company’s complement inhibitor and innate anti-inflammatory product candidate, is being developed as a treatment for hypoxic ischemic encephalopathy and other acute inflammatory and rare diseases.
The Phase 1b clinical trial (Protocol RLS-0071-103; NCT05351671) is a proof-of-mechanism (POM) study intended to establish RLS-0071 translatability from animal disease models of acute lung injury and other acute pulmonary exacerbations to humans by inhibiting neutrophil-mediated inflammation at the tissue level. The new data will be presented by Prof. Dr. Jens M. Hohlfeld, Division Director of Airway Research at the Fraunhofer Institute for Toxicology and Experimental Medicine (Hannover, Germany) and lead investigator on the Phase 1b trial.
Details of the presentation:
|
Title |
Safety and Efficacy of RLS-0071 on Neutrophils and Inflammatory Mediators in a Phase 1b Inhaled LPS Study |
|
Authors |
Jens M. Hohlfeld, Olaf Holz, Meike Müller, Saskia Carstensen, Linda Dell, Jessica Goss, Pam Hair, Philipp Badorrek, Kenji Cunnion, Ulrich Thienel |
|
Presentation |
PS-6 in Poster Area; Allianz MiCo Convention Centre, Level +2, Hall 4 |
|
Session |
Session 68 (PA608) – From bench to bedside: translational studies in airway diseases |
|
Date/time |
Sunday, 10 September, 08:00 – 09:30am GMT+2 |
About ReAlta Life Sciences
ReAlta Life Sciences, Inc. is a clinical-stage biotech company dedicated to harnessing the power of the immune system to address life threatening acute inflammatory and rare diseases. The Company’s EPICC peptides are based on research into the human astrovirus, HAstV-1, which causes a non-inflammatory, self-limiting gastroenteritis unique among viruses by inhibiting components of the innate immune system. ReAlta’s therapeutic peptides leverage these virus-derived mechanisms to rebalance complement and inflammatory processes in the body. The company’s pipeline is led by RLS-0071, which has received IND clearance, and Orphan Drug Designation by the U.S. Food and Drug Administration and European Medicines Agency for the treatment of hypoxic-ischemic encephalopathy (HIE) in neonates. The company launched in 2018 and is located in Norfolk, Virginia. For more information, please visit www.realtalifesciences.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230905292669/en/
Contact information
John Rickman
Chief Financial Officer
jrickman@realtals.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Thredd Becomes First Issuer-Processor to Offer Real Time Control over B2B Travel Payments through the Mastercard Wholesale Program12.8.2025 10:00:00 EEST | Press release
Thredd, a leading next-generation global issuer processor, today announced it has become the first to offer its travel agency customers real time payment control through new flexible product codes made possible through the Mastercard Wholesale Program (MWP). This new capability enables Thredd’s customers to better respond to supplier needs based on geography, product type and volume, while optimizing business-to-business travel payments through greater visibility, adaptability, and control. The MWP was designed to better support the global nature of the travel industry, offering greater security and predictability of cross-border payments between travel buyers and suppliers. Based on industry feedback, the Program has now evolved to provide real-time payment control, allowing issuers to seamlessly transition between product codes on a real-time basis. These product codes allow travel organizations to adapt virtual card technology in real time, based on supplier or product need. Thredd
500 Global Launches Sustainable Innovation Program Backed by Catalytic Partners12.8.2025 09:00:00 EEST | Press release
500 Global, one of the world’s most active venture capital firms1, announced today the launch of its Sustainable Innovation Program, an initiative designed to support mission-driven founders building commercially viable solutions to sustainability challenges across the global south. Rooted in the belief that the next generation of global growth will be driven by sustainable, inclusive innovation rooted in local leadership, the Sustainable Innovation Program brings together strategic capital, multilateral partnerships, and deep domain expertise to help entrepreneurs scale ventures that deliver both market returns and measurable impact. Their catalytic partner is the Shell Foundation, with co-funding from the UK Government as part of its Transforming Energy Access (TEA) platform and Catalysing Agriculture by Scaling Energy Ecosystems (CASEE) programme. This is the first of these partnerships focused on investing in human capital across agriculture, energy, mobility, and the built environ
Access Advance Video Distribution Patent Pool Gains Further Momentum with the Signing of Alibaba, ZTE, and Youku12.8.2025 03:00:00 EEST | Press release
Access Advance LLC today announced that Alibaba Group and ZTE Corporation have joined the Video Distribution Patent ("VDP") Pool as Licensors and Alibaba Group’s subsidiary Youku, one of China's leading video streaming platforms, has joined as a Licensee. The participation of these industry leaders strengthens the VDP Pool's comprehensive licensing solution by adding extensive patent portfolios, including significant contributions to both the HEVC/H.265 and the VVC/H.266 standard, while expanding coverage to Youku's massive user base. "We're delighted to welcome Alibaba, ZTE and Youku to the VDP Pool," said Peter Moller, CEO of Access Advance. "The addition of Alibaba and ZTE as Licensors brings critical intellectual property assets to the VDP Pool, while Youku's participation as a Licensee demonstrates the value of the pool's flexibility, predictable cost model, and simplified administration for major streaming platforms. They join other technology leaders including ByteDance, Kuaisho
First Cessna SkyCourier in Mongolia to Join Hunnu Air Fleet, Enhancing Operations in Asia-Pacific Region11.8.2025 17:00:00 EEST | Press release
The Cessna SkyCourier is making its entry into Mongolia with charter operator Hunnu Air placing the first order for the versatile twin-engine turboprop aircraft in the country. Hunnu Air will use the Cessna SkyCourier to enhance domestic tourism and cargo operations within Mongolia. The order includes two passenger variants of the Cessna SkyCourier aircraft and one Cessna Grand Caravan EX, with deliveries of their new aircraft expected to begin in 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250811928514/en/ First Cessna SkyCourier in Mongolia to join Hunnu Air fleet, enhancing operations in Asia-Pacific region (Photo Credit: Textron Aviation) The Cessna SkyCourier is designed and produced by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. "Designed for versatility and performance, the Cessna SkyCourier is a strong fit to support Hunnu Air’s services across Mongolia,” said Lannie O’Bannion, senior vice pres
84% of Consumers Would Switch Banks Over Financial Crime Links, ThetaRay Report Finds11.8.2025 17:00:00 EEST | Press release
ThetaRay, a global leader in Cognitive AI financial crime compliance, today released its U.S. Banking & Fintech Trust Report 2025, offering new insights into consumer attitudes toward anti-money laundering (AML) practices. The report reveals that 84% of consumers would switch banks if linked to financial crime, and 87% would actively warn family and friends against using that institution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250811009362/en/ Brand reputation is one of a financial institution’s most valuable and vulnerable assets, built over years through trust, consistency, and significant investment. Encouragingly, 93% of respondents express either positive or neutral sentiments toward their current financial providers, suggesting a strong foundation of customer trust. But that trust is fragile: a single incident of financial crime can shatter a reputation overnight, triggering customer attrition, regulatory penal
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom